May 02, 2012, 03.04 PM | Source: Moneycontrol.com
Orchid Chemicals and Pharmaceuticals has got US FDA okay for Naratriptan Tablet, reports CNBC-TV18.
It touched an intraday high of Rs 183.40 and an intraday low of Rs 178.90. At 15:00 hrs the share was quoting at Rs 181.80, up Rs 2.15, or 1.20%.
It was trading with volumes of 124,178 shares. In the previous trading session, the share closed up 1.21% or Rs 2.15 at Rs 179.65.
The company's trailing 12-month (TTM) EPS was at Rs 22.64 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 8.03. The latest book value of the company is Rs 160.99 per share. At current value, the price-to-book value of the company was 1.13. The dividend yield of the company was 1.65%.
Avinash Gorakshakar, Market Expert advises exiting
According to Prakash Gaba of prakashgaba.com, one
The company had posted a net loss of Rs 94.02 cror